MMJ Recs

FEBRUARY 27, 2024

Common qualifying conditions include but are not limited to: Cancer: Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Crohn’s Disease: Crohn’s disease is a chronic inflammatory bowel disease that affects the digestive tract.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Leafwell

APRIL 14, 2021

Functional Neurological Disorder (FND) is a disorder that breaks down the communications between the brain and the body. The symptoms of FND can often seem similar to neurological diseases such as multiple sclerosis (MS).

Chronic Pain 82

Chronic Pain Cannabis Conditions Marijuana 82

The Fresh Toast

FEBRUARY 18, 2020

Researchers said a new strategy is 'a potentially promising way to slow the progression of Parkinson’s disease and related neurological disorders.'. Continue reading Marijuana And Parkinson’s Disease: What New Research Uncovered at The Fresh Toast.

Marijuana 98

Marijuana Cannabis 98

Cannabis Law Report

APRIL 28, 2023

(“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has commenced a Phase II clinical trial for its proprietary […] (..)

Clinical Trials 52

Clinical Trials Pharmaceutical Patients Business 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. It is expected to be worth USD 2.1

Access 105

Access Research and Development Pharmaceutical Therapy 105

PrestoDoctor

SEPTEMBER 1, 2020

Millions of people in the world are currently experiencing neurodegenerative diseases. Neurodegenerative diseases can even lead to death. Over the years, experts have been studying neurodegenerative diseases to learn more about them. What Are Neurodegenerative Diseases? What Is Sativa Cannabis? Anti-Inflammatory.

Patients 98

Patients Sativa Treatment Conditions 98

Cannabis Law Report

APRIL 2, 2023

(“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has successfully […]

Extraction 52

Extraction Pharmaceutical Patients Business 52

Cannabis Law Report

JANUARY 24, 2023

(CSE: LOBE) (OTCQB: LOBEF) (“Lobe” or the “Company”), a North American biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced its Board of Directors voted to receive shares in Lobe in lieu of the traditional […]

Medicine 52

Medicine 52

MMJ Recs

DECEMBER 28, 2023

From chronic pain to neurological disorders, understanding the breadth of MMJ’s applications provides a comprehensive view of its role in modern healthcare. However, integrating medical marijuana into cancer care requires careful consideration of individual patient needs, potential drug interactions, and legal regulations.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 16, 2022

These products are potentially useful in treating addiction, depression, post-traumatic stress disorder (PTSD), and other neurologic diseases. Congress recently introduced a bill that could expand access to therapeutic psychedelics that are designated as Breakthrough Therapies.

Research and Development 52

Research and Development Therapy Access 52

FloridaMarijuana.net

JUNE 12, 2018

There are numerous types of seizures and although the cause of epilepsy cannot be determined, there is speculation that a variety of issues can lead to seizures including: traumatic brain injury, serious illness or very high fever, stroke, brain tumors/cysts, dementia/Alzheimer’s disease, prenatal injury or other neurological diseases.

Epilepsy 187

Epilepsy Patients Marijuana Research and Development 187

Cannabis Law Report

JUNE 29, 2022

This cannabinoid has been shown to have a number of health effects, such as reducing inflammation and the growth of skin and other cancer cells, as well as having benefits for those with Crohn’s disease. This is exciting news for people who are at risk for neurological conditions like Alzheimer’s disease.

Cannabinoids 98

Cannabinoids Conditions Hemp THC 98

United Patients Group

AUGUST 24, 2023

Immune System : CB2 receptors, primarily found in immune cells, play a key role in regulating inflammation and immune response, critical aspects of the body’s defense mechanisms against pathogens and diseases.

Cannabinoids 98

Cannabinoids Marijuana Digestion THC 98

MedicalJane

OCTOBER 19, 2022

Crohn’s disease. Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies. Huntington’s disease. Inflammatory bowel disease. Neurodegenerative diseases. Parkinson’s disease. HIV / AIDS.

Marijuana 99

Marijuana Therapy Programs Patients 99

FloridaMarijuana.net

AUGUST 15, 2018

The National Institute of Neurological Disorders and Stroke website states that neuropathy may be either inherited or acquired through disease processes or trauma. Diseases or disorders and their related processes (such as inflammation) can be associated with neuropathy. Small vessel disease. Autoimmune diseases.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

MedicalJane

JUNE 12, 2020

Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

FloridaMarijuana.net

AUGUST 16, 2018

Dementia is not a specific disease. Their mission is to enhance the quality of life for those living with Dementia and caregivers as this disease has become a global epidemic. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

United Patients Group

JANUARY 31, 2023

Cannabis and Dementia: Are There Benefits Introduction Dementia is a debilitating disease that affects millions of people across the world. A common cause of dementia is Alzheimer’s disease, which causes a decline in memory functions and other cognitive abilities. Here are some safe and tested products to look at.

Sleep 104

Sleep Cannabinoids THC Patients 104

Veriheal

JANUARY 24, 2023

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. But now that the DEA has approved [18F]FP-CIT for Parkinson’s disease research, we may see a change in the near future. So what gives?

DEA 98

DEA Treatment Medicine Pets 98

Cannabis Law Report

JULY 6, 2021

TSXV: NUMI) (OTC: LKYSF) is buying the Neurology Centre of Toronto as of an agreement dated July 2, 2021, in a deal valued at half a million dollars. The need to develop novel therapies that address both medical and psychological components of neurological diseases may be substantial and the potential impact could be significant.

Therapy 66

Therapy Research and Development Treatment Patients 66

The Cannigma

FEBRUARY 25, 2021

In other words, BCP may aid in treating or preventing a multitude of conditions like infections, spasms, pain, and other neurologic conditions. Another promising aspect of b-caryophyllene is the ability to help treat neurologic disease. Pain is one of the primary conditions BCP is thought to benefit. Andriy Popov/123rf).

Terpenes 107

Terpenes Oil Cannabinoids Conditions 107

MMJ Recs

NOVEMBER 8, 2023

Conditions that qualify for MMJ treatment in Ohio include chronic pain, cancer, HIV/AIDS, epilepsy, Parkinson’s disease, multiple sclerosis, and many others. The state’s medical marijuana program includes a growing list of qualifying conditions, allowing more patients to explore the benefits of medical cannabis.

Access 52

Access Chronic Pain Conditions Patients 52

The Joint Blog

FEBRUARY 24, 2021

For decades cannabis researchers have been investigating the impact cannabis has on neurological diseases. Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This looked into the deeper reasons behind diseases like Parkinson’s.

Treatment 55

Treatment Clinical Trials Collective Patients 55

United Patients Group

JANUARY 16, 2023

THCV may help fight Alzheimer’s disease by reducing inflammation in the brain and restoring nerve function. THCV may help prevent brain damage from strokes and other neurological disorders. THCV has been used to treat diabetes and slow the progress of Alzheimer’s disease in mice. It helps improve cholesterol levels.

Cannabinoids 85

Cannabinoids Epilepsy Chronic Pain THC 85

United Patients Group

JULY 7, 2023

Medical cannabis, also known as medical marijuana, refers to the use of the cannabis plant or its extracts to treat symptoms of disease or other medical conditions. Epilepsy is a neurological disorder characterized by recurrent seizures.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

MAY 12, 2022

This partnership is hugely exciting for us as we look to develop a portfolio of clinical assets that provide solutions to the devastating effect of psychiatric and neurological disorders.”. Broad collaboration with Lophora will further strengthen Beckley Psytech’s world class management and R&D team.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Greencamp

APRIL 23, 2019

Multiple Sclerosis (otherwise known as MS) is an unpredictable, progressive neurological autoimmune disease that gradually damages the nerves of the spinal cord and brain, along with the entire immune system. This myelin deficiency disease gradually deteriorates the nerve cells, and eventually damages them permanently.

Research and Development 94

Research and Development Strains Patients Treatment 94

Cannabis Law Report

NOVEMBER 10, 2021

While research is ongoing, both doctors and patients have reached agreement that medical marijuana helps in five key areas: pain management, mental health, inflammation, certain neurological conditions, and sleep. It’s also associated with Crohn’s disease and irritable bowel syndrome. Certain Neurological Conditions.

Marijuana 52

Marijuana Sleep Chronic Pain Conditions 52

Veriheal

APRIL 7, 2022

Multiple sclerosis (MS) is an autoimmune disease that can have very serious implications for those living with it. The disease is chronic and rather unpredictable but can significantly decrease the quality of life for the current estimate of 2.3 million people worldwide who have been diagnosed with MS. The Need for Better MS Treatment.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Law Report

AUGUST 15, 2021

As we embark on our next phase of growth, our strong syndicate of expert investors will support us in bringing much-needed innovative treatments to patients suffering from neurological and psychiatric conditions.” August 15, 2021 07:01 PM Eastern Daylight Time. Beckley Psytech – www.beckleypsytech.com.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Cannabis Law Report

SEPTEMBER 22, 2021

Depression), rare and near-rare neurological (i.e. Parkinson’s disease, Amyotrophic lateral sclerosis), and pain disorders. PharmaTher is currently conducting an FDA approved phase 2 clinical study with ketamine to treat Parkinson’s disease and is developing novel microneedle patches for the intradermal delivery of psychedelics.

Research and Development 52

Research and Development Pharmaceutical Conditions Business 52

SpeedWeed

JUNE 14, 2021

On Wednesday, the Ohio State Medical Board announced that it had approved Huntington’s disease, terminal disease and spasticity to the list of approved conditions. Huntington’s disease is a rare, hereditary, neurological disease that leads to the breakdown of nerve cells in the brain.

Conditions 40

Conditions Programs Therapy Patients 40

Veriheal

AUGUST 17, 2023

Within the press release, the OLCC advised consumers of the dangers of arsenic and associated diseases: “Consumers should be aware that arsenic is carcinogenic and considered to cause a variety of diseases. Low-level exposure over an extended period, however, could result in kidney, lung, and bone-related diseases.

Extraction 98

Extraction Safety Concentrates Cannabis 98

Kind Meds (Cannabis Education Blog)

AUGUST 16, 2021

Neurological Inflammation. One of the biggest places that we’ve seen medical breakthroughs regarding cannabinoids is in neurological diseases. Cannabis has been shown to be helpful with Parkinson’s disease, Huntington’s disease, Tourette’s, MS, encephalomyelitis, and many other diseases. The Big CTE.

Marijuana 111

Marijuana Chronic Pain Tincture Cannabinoids 111

Cannabis Law Report

NOVEMBER 22, 2019

MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). for its THC and CBD proprietary drug formulation which will be used for the treatment of Huntington’s Disease. For more information visit: [link]. 561-627-9455.

DEA 66

DEA Clinical Trials THC Research and Development 66

Miss Marijuana

JULY 26, 2020

Agitation of Alzheimer’s disease. Crohn’s Disease. Neuro-Behcet’s Autoimmune Disease. Parkinson’s Disease. Polycystic Kidney Disease. Spinal cord disease (including but not limited to Arachnoiditis). Spinal cord injury (damage to the nervous tissue of the spinal cord with objective neurological.

Chronic Pain 96

Chronic Pain Marijuana Conditions Epilepsy 96

Miss Marijuana

JULY 26, 2020

Crohn’s disease. Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies. HIV / AIDS; Huntington’s disease. Inflammatory bowel disease. Neurodegenerative diseases. Neuropathies.

Marijuana 52

Marijuana Chronic Pain Therapy Epilepsy 52